CN105685325A - Highland barley blood pressure reducing tea (instant herbal medicine) - Google Patents
Highland barley blood pressure reducing tea (instant herbal medicine) Download PDFInfo
- Publication number
- CN105685325A CN105685325A CN201610154782.3A CN201610154782A CN105685325A CN 105685325 A CN105685325 A CN 105685325A CN 201610154782 A CN201610154782 A CN 201610154782A CN 105685325 A CN105685325 A CN 105685325A
- Authority
- CN
- China
- Prior art keywords
- blood pressure
- blood
- effect
- highland barley
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036772 blood pressure Effects 0.000 title claims abstract description 47
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 6
- 235000007340 Hordeum vulgare Nutrition 0.000 title abstract description 15
- 240000005979 Hordeum vulgare Species 0.000 title abstract 4
- 241000411851 herbal medicine Species 0.000 title abstract 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 50
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 33
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 30
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 30
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 28
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims abstract description 27
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 27
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims abstract description 27
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims abstract description 27
- 229940025878 hesperidin Drugs 0.000 claims abstract description 27
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 27
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960003080 taurine Drugs 0.000 claims abstract description 25
- 108010028690 Fish Proteins Proteins 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims description 34
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 75
- 210000004369 blood Anatomy 0.000 abstract description 44
- 239000008280 blood Substances 0.000 abstract description 44
- 230000003405 preventing effect Effects 0.000 abstract description 15
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 13
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract description 11
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 10
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 9
- 206010028980 Neoplasm Diseases 0.000 abstract description 8
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 6
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract description 6
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 abstract description 3
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 abstract description 3
- 235000001046 cacaotero Nutrition 0.000 abstract description 3
- 229940110767 coenzyme Q10 Drugs 0.000 abstract description 2
- 235000018927 edible plant Nutrition 0.000 abstract 1
- 235000001497 healthy food Nutrition 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 38
- 238000011160 research Methods 0.000 description 30
- 230000036039 immunity Effects 0.000 description 20
- 230000006870 function Effects 0.000 description 18
- 239000000126 substance Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 235000012000 cholesterol Nutrition 0.000 description 13
- 241000209219 Hordeum Species 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 230000000968 intestinal effect Effects 0.000 description 11
- 229920002307 Dextran Polymers 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 230000002708 enhancing effect Effects 0.000 description 10
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 206010010774 Constipation Diseases 0.000 description 9
- 206010019280 Heart failures Diseases 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 9
- 230000003064 anti-oxidating effect Effects 0.000 description 9
- 206010016256 fatigue Diseases 0.000 description 9
- 229910052753 mercury Inorganic materials 0.000 description 9
- 206010008190 Cerebrovascular accident Diseases 0.000 description 8
- 208000006011 Stroke Diseases 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000013325 dietary fiber Nutrition 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000035790 physiological processes and functions Effects 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000002000 scavenging effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 5
- 101800000733 Angiotensin-2 Proteins 0.000 description 5
- 102400000345 Angiotensin-2 Human genes 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 5
- 229920002498 Beta-glucan Polymers 0.000 description 5
- 229950006323 angiotensin ii Drugs 0.000 description 5
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 description 5
- 230000000711 cancerogenic effect Effects 0.000 description 5
- 231100000357 carcinogen Toxicity 0.000 description 5
- 239000003183 carcinogenic agent Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 230000010534 mechanism of action Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000004165 myocardium Anatomy 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 229940035936 ubiquinone Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010028594 Myocardial fibrosis Diseases 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 239000003613 bile acid Substances 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101800004538 Bradykinin Proteins 0.000 description 2
- 102400000967 Bradykinin Human genes 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000006029 Cardiomegaly Diseases 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 102000019280 Pancreatic lipases Human genes 0.000 description 2
- 108050006759 Pancreatic lipases Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- -1 vitamin compounds Chemical class 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- UDIODXADSSQKTM-GUHNCMMLSA-N (5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one;(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5- Chemical compound ClCCN(CCCl)P1(=O)NCCCO1.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3C(O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 UDIODXADSSQKTM-GUHNCMMLSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010072661 Angiotensin Amide Proteins 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 101000929923 Caenorhabditis elegans Acetylcholinesterase 1 Proteins 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010011906 Death Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010010164 Hypertension complications Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 206010024119 Left ventricular failure Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003138 coordinated effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses highland barley blood pressure reducing tea (instant herbal medicine), and belongs to healthy food or healthcare food. Especially, extract of natural, pollution-free and high-quality medical and edible plant highland barley in the Qinghai-Tibet Plateau, fish protein tripeptide, coenzyme Q10, taurine, hesperidin and cacao polyphenol are adopted as raw materials, and the highland barley blood pressure reducing tea has the effects of reducing blood pressure, blood fat and blood sugar, losing weight, relaxing the bowels, preventing and treating the cardiovascular and cerebrovascular diseases, resisting cancer, preventing tumors and the like.
Description
One, technical field: the invention belongs to health food or health food。Especially with Qinghai-Tibet Platean natural pollution-free high-quality medicine food dual purpose plant Semen avenae nudae extract, fish protein tripeptides, ubiquinone10, taurine, Hesperidin, cocoa polyphenol be raw material, take health food or health product that the most modern advanced technologies makes。
Two, background technology: the present invention is especially with Semen avenae nudae extract, fish protein tripeptides, ubiquinone10, taurine, Hesperidin, the Raw material processing such as cocoa polyphenol a kind of new product。This product has the effects such as blood pressure lowering, blood fat reducing, blood sugar lowering, fat-reducing, relieving constipation, preventing and treating cardiovascular and cerebrovascular disease, anti-cancer and cancer-preventing。Also not having like product, innovation to research and develop this product in the market can be reduce blood pressure to hyperpietic to provide a kind of innovative product。The new product that reduces blood pressure that this product is made with the pollution-free high-quality dual purpose plant of pure natural and bioactive ingredients for raw material, purity height, good absorbing, biological activity is strong, mouthfeel good, taking convenience, without any side effects, effect substantially, be adapted to each age group blood pressure lowering crowd and take。
Three, summary of the invention: hypertension is a kind of modal chronic disease, is also the topmost risk factor of cardiovascular and cerebrovascular disease, and its major complications has the diseases such as apoplexy, myocardial infarction, heart failure and chronic kidney disease。Along with developing rapidly of China's economy, its people's dietary structure and living-pattern preservation, the hyperpietic of China leads obvious rising。According to statistics, the existing hyperpietic of China is about more than 200,000,000, and is also increasing with the speed of newly-increased more than 600 ten thousand people every year, dies from apoplexy and hypertension complication patient more than 150 ten thousand every year, and disabled person reaches millions of。More seriously, if blood pressure can not obtain good control for a long time, causing other even more serious disease apoplexy (apoplexy), apoplexy has become as the number one killer causing death that the whole world is generally acknowledged。Therefore, the medicine preventing and treating hypertension is always up the focus of innovative development。
Four, composition of raw materials: Semen avenae nudae extract 10-100 kilogram, fish protein tripeptides 5-10 kilogram, ubiquinone101-2 kilogram, taurine 3-7 kilogram, Hesperidin 5-8 kilogram, cocoa polyphenol 5-10 kilogram be raw material。
Five, technical scheme:
(1) Semen avenae nudae (barley), cries again Fructus Hordei Vulgaris, Semen avenae nudae etc.。Semen avenae nudae is grass family Hordeum kernel maturity seed。Property flat, salty in the mouth, return spleen, stomach, large intestine channel。There is effect of strengthening the spleen and nourishing the stomach, QI invigorating antidiarrheal, strong lean power, dehumidifying diaphoresis。Adapting to deficiency of spleen-QI and stomach-QI, lassitude, the just Tang person that suffers from diarrhoea eats。The effects such as modern medicine research shows, Semen avenae nudae has blood fat reducing, reduces cholesterol, blood sugar lowering, blood pressure lowering, prevention cardiovascular disease, fat-reducing, relieving constipation, anticancer, enhancing immunity, improving eyesight eye protection。
Chemical composition: Semen avenae nudae contains the compositions such as protein, fat, carbohydrate, dietary fiber, anthocyanidin, multivitamin, several mineral materials and trace element。
Physiological function: 1, enhancing immunity: zoopery proves, in Semen avenae nudae, beta glucan has enhancing immunity function。Carry out rat peritoneal macrophages with highland barley Beta-dextran produce interleukin (IL-1) and cultivate spleen cell induction generation IL-2, the test of interferon (INF-γ) and IL-4, result confirms, highland barley Beta-dextran can play inducing action, and edible highland barley Beta-dextran has the effect of life-saving for infecting staphylococcus aureus simultaneously。Research is thought, it is by stimulating cell SEB system that highland barley Beta-dextran can strengthen the mechanism of action of immunologic function, makes body produce INF-γ, thus enhancing human body immunity power。
2, blood pressure lowering: research is thought, Semen avenae nudae is except having reduction cholesterol and hypoglycemic effect, and Semen avenae nudae also has efficacy in lowering high blood pressure。It is reported the people patient to 18 men and women's mild hypertension diseases and hyperinsulinemia, test with rich beta glucan Semen avenae nudae wholegrain powder breakfast, result shows, picked-up Semen avenae nudae breakfast group patient's systolic blood pressure substantially reduces and substantially reduces with blood pressure expansionary phase, observing and also find, the T-CHOL of Semen avenae nudae breakfast picked-up group patient, LDL (bad cholesterol) and serum glucose are also decreased obviously。Experiment results proved, the food of picked-up highland barley Beta-dextran can obviously reduce hypertension therapeutic medicine and consumption, improves the control to blood pressure, has the effect treating and preventing hypertension。It addition, analyze it is also shown that the anthocyanidin that Semen avenae nudae contains has antiinflammatory, antioxidation, improves microcirculation and improve blood vessel elasticity, therefore, having the effect of blood pressure lowering, it functions as hypertensin enzymeinhibitor (ACE-1)。According to another report, Semen avenae nudae, beta glucan can not be digested and assimilated in human body, have the increment effect of bifidus bacillus, can strengthen cell function, it is prevented that body is infected and repairs destroyed tissue。People are due to the reason of physics or stress, cause that immunity reduces, under radiation environment or irrational meals immunity all can be made impaired, highland barley Beta-dextran can promote improve resistance, reduce the infringement infecting disease, be remarkably reinforced immunity and antitumaous effect。The harm that computer fluorescent screen Radiation On Human body causes is reduced it addition, also have。
3, blood sugar lowering: highland barley Beta-dextran can improve the stickiness of food digestion thing, thus postponing the absorption of glucose, reaches hypoglycemic effect。Animal experiment shows, hyperglycemia model rat is fed with the base material rich in highland barley Beta-dextran, after 8 weeks, in rat serum, blood glucose reduces by 58.9% than hyperglycemia matched group, within 30 minutes after the meal, the half congealed lift-off value of blood reduces by 62.7% and 76.7% than Normal group and hyperglycemia matched group respectively, and highland barley Beta-dextran has the effect regulating blood glucose。The diseases such as result of the test also confirms that, highland barley Beta-dextran scalable insulin level, the diabetes that prevention and auxiliary treatment are caused by carbohydrate tolerance。Its mechanism of action is that in Semen avenae nudae, beta glucan expands increase volume, the decrease of power density, it is suppressed that amylase activity, the metabolism of interference sugar after intestinal absorption, has delayed the human body absorption to glucose, thus reducing fasting glucose and post-prandial glycemia。
4, blood fat reducing and cholesterol: Semen avenae nudae can substantially resist the arteriosclerosis caused by high lipid food to feeding animal, can make activity increase, and serum cholesterol reduces, notable high density lipoprotein increasing。Semen avenae nudae can also reduce the content of serum cholesterol and triglyceride, can also suppress diet induced hepatic tissue cholesterol simultaneously, and triglyceride, LPO increase。Therefore, there is the effect of good blood fat reducing and cholesterol。Semen avenae nudae contains substantial amounts of water soluble dietary fiber material and beta glucan, can absorb large quantity of moisture, and form colloid substance, can stop intestinal wall Cell uptake lipid, play the effect of blood fat reducing after entering intestinal。
5, fat-reducing: research shows, the food that Semen avenae nudae contains a large amount of dietary fiber is effectively reduced the hunger sensation of human body, thus the purpose with body weight that reaches to keep on a diet。Research finds, Semen avenae nudae is that therefore, Semen avenae nudae can effectively control human body appetite, plays the effect of fat-reducing containing the food enriching dietary fiber, the absorption of controllable energy and the hormone generation beneficial effect to human metabolism and scalable appetite。It addition, the dietary fiber in Semen avenae nudae can be combined with partial fatty acid, make fatty acid can not be absorbed when passing through digestive tract, adiposis patient is played slimming effect。
6, toxin expelling: research shows: in Semen avenae nudae, hydrargyrum, arsenic, cadmium and other heavy metals are had scavenging action and Organic substance has absorption chelation by dietary fiber。Semen avenae nudae can adsorb cholesterol, the Organic substance of bile acid etc, it is suppressed that absorption of human body, the also noxious substance in adsorbable intestinal (endogenous toxin), chemical drugs (exogenous poisonous substance) by chelating, and is got rid of external。
7, prevent constipation: the time that the abundant fiber in Semen avenae nudae can make food pass through in intestinal shortens, and makes the feces amount of big enteral relatively increase, contributes to the wriggling of large intestine, make feces be prone to discharge, thus reaching the anti-effect treated constipation。
8, prevention colorectal cancer: research finds, the generation of colorectal cancer is main and toxin and carcinogen long term accumulation in intestinal, relevant with the factor such as intestinal mucosa Long Term Contact, thus being susceptible to colorectal cancer。And Semen avenae nudae contains abundant food fiber of rising and can adsorb the carcinogen in large intestine, carcinogen concentration is made relatively to reduce。In addition dietary fiber has the effect stimulating intestinal peristalsis promoting, accelerate to empty the intestine toxin and carcinogen, shortens the food time of staying at large intestine, makes carcinogen excrete with stool in time。Additionally, Semen avenae nudae also can improve the probiotic bacteria of large intestine, increase enteral antioxidant, therefore, have the effect of preventing and treating colorectal cancer。
It addition, Semen avenae nudae also has enhancing immunity, preventing cardiovascular and cerebrovascular disease, anti-hypoxia, slow down aging, bowel relieving etc. acts on。
(2) fish protein tripeptides (Threefishproteinpeptide), fish protein tripeptides is that the ratio protein molecule that the class of amino acid made through zymolysis technique forms is little, but there is the little molecule tripeptides of super nutritive and regulation of physiological functions, be also that a class relates to the bioactive substance of various functions in organism。Fish protein tripeptides except as super nutritive element, can be complete directly absorb from digestive tract, therefore, fish protein three Toplink preventing and treating numerous disease。There is blood pressure lowering, blood fat reducing, reduction blood cholesterol level, it is prevented that blood vessel wall is aging after increasing, suppress the effects such as arteriosclerosis, anti-apoplexy, myocardial infarction, heart failure, anti-high blood ester disease。
Physiological function: 1, blood pressure lowering: research finds, fish protein three Toplink combines with Angiotensin-Converting, thus changing the active structure of angiotensin converting enzyme, make the loss of activity of its enzyme, thus playing the effect dropping blood, research also shows, normal arterial pressure is had no effect by fish protein tripeptides at blood pressure lowering simultaneously。According to domestic, fish protein tripeptides feeds the mouse suffering from hypertension, and after 6 weeks, the blood pressure of these mouse on average reduces 20-25 millimetres of mercury, maximum decreases by 30 millimetress of mercury, and effect is extremely notable。According to another external report, clinical trial shows, the fish protein tripeptides that picked-up every day is appropriate, after 4 weeks, the blood pressure of hyperpietic reduces 10 millimetress of mercury。Its mechanism of action, makes fish protein tripeptides have and suppresses vasoconstriction and suppress effect of converting Enzyme activity。
It addition, fish protein tripeptides also has reduction blood cholesterol level, protect cardiovascular, it is suppressed that the disease such as arteriosclerosis, lipidemia disease, anti-cardiac muscle stalk, heart failure, apoplexy。
(3) ubiquinone10(COENZYMEQ10), also known as ubiquinone, its reduced form claims pantothenylol, it is a kind of coenzyme, belongs to organism lactone soluble vitamin compounds, be present in each cell of human body, it it is cell mitochondrial conversion agent, also being a kind of living matter, modern medicine study shows, coenzyme Q10 can improve energy, blood pressure lowering, blood fat reducing, blood sugar lowering, enhancing immunity, resisting fatigue, cancer-resisting, preventing and treating cardiovascular and cerebrovascular disease, antioxidation, defying age, skin maintenance。Be used for clinically treating heart disease, heart failure, dilatancy cardiomyopathy, confirmed fatigue syndrome, cancer more after, be afraid of gold Lignum Rhamnellae chronic disease。
Physiological function: 1, blood pressure lowering: research shows, ubiquinone10There is significant hypotensive activity, to 46 male and 37 female hypertensives 12 weeks double-blind trials by a definite date, it was found that take appropriate ubiquinone every day10Patient, its shrink flatten all reduce by 17 millimetress of mercury, low 10 millimetress of mercury of tensioned pressure drop, according to another external report, 109 hyperpietics are taken ubiquinone every day by research worker10, average systolic can be made from 159 millimetress of mercury, be reduced to 147 millimetress of mercury, diastolic pressure is reduced to 85 millimetress of mercury from 94 millimetress of mercury, and people's blood pressure of 85% is significantly reduced。
2, blood sugar lowering: ubiquinone10Synthesis and the secretion of insulin can be promoted, it is possible to promote conversion and the utilization of sugar, it is prevented that sugar is accumulated in vivo, effectively reach to regulate the purpose of blood glucose。Therefore, can be used to clinically treat diabetic cardiovascular complications。
3, preventing and treating cardiovascular and cerebrovascular disease: research finds, ubiquinone10The metabolism of cardiac muscle and brain cell, the integrity of protection cardio-cerebrovascular cell biofilm structure can be strengthened, improve the speed of heart and the stability of the rhythm and pace of moving things。Due to ubiquinone10The damage of radical pair tunica intima can also be stoped, therefore can the generation of atherosclerosis, there is the effect of preventing and treating cardiovascular and cerebrovascular disease。
4, immunity is improved: research shows, ubiquinone10There is the effect improving immunity。Research is thought: ubiquinone10Cell has the effect that stimulatory function improves, and every day takes ubiquinone10, immunoglobulin g antibody in the patient can be made to been significantly enhanced, therefore, ubiquinone10Immunity can be improved。
5, preventing and treating heart failure and cardiac dilatation disease: heart failure is referred to as cardiomyopathy, is that a kind of fatal myocardium strength is weak, and it is the one that aged patients with heart diseases is the most dangerous。When there is this symptom, heart becomes big, and it is heart failure that cardiac muscle strength deficiency can not extrude enough blood。Its reason is that human body lacks ubiquinone10, famine ubiquinone in cardiac's heart tissue of 75%10, the cardiovascular and cerebrovascular disease gerontal patient of 3/4 has taken ubiquinone10Increasing cardiac output, reduce Peripheral resistance, the treatment that favourable heart failure is sick, the state of an illness has had and has been clearly better, and separately studies have reported that, ubiquinone10Heart failure and the treatment of cardiac dilatation disease patient it is used for clinically in heart disease。
6, slow down aging: research display, ubiquinone10Can keep the human body youth persistently, defying age。Zoopery confirms, ubiquinone10Mouse adolescence can be made to extend, and do not take ubiquinone10Mouse of the same age compare, they seem active especially, but have arrived end of life, and those have taken ubiquinone10The situation of mouse become better and better。Therefore, coenzyme has the effect of good slow down aging。
It addition, ubiquinone103Also there is protection brain, resisting fatigue, raising cellular energy antioxidation, prevent and treat the functions such as apoplexy, myocardial infarction, arrhythmia, angina pectoris, atherosclerosis, cancer-resisting, delay skin aging, skin maintenance。
(4), taurine (TaurineTau), also known as taurine, be a kind of sulfur-containing amino acid, but be not involved in the synthesis of protein。Taurine is distributed widely in mammiferous internal each histoorgan with the form of free amino acid, such as central nervous system, retina, liver, skeletal muscle, hemocyte, thymus and adrenal gland etc.。Especially cerebral tissue content is the highest。There is maintenance osmotic pressure, regulate the various biological effect such as cell calcium stable state and stabilizing cell membrane。Modern medicine study shows, taurine has blood pressure lowering, enhancing immunity, blood fat reducing, blood sugar lowering, improves memory, enhancing development, resisting fatigue, antioxidation, hepatic cholagogic, slow down aging, improve anemia, alleviating asthenopia, relieving constipation, beauty treatment, protection skin beauty water grade function。
1, enhancing immunity function: Immunity regulation is played an important role by taurine。Leukocyte kills antibacterial by producing hypochlorous acid, if but when hypochlorous acid is too much reaction destroy leukocyte self, taurine then can be combined with hypochlorous acid, generates innocuous substance, and nature will protect leukocyte。Studies have found that again in recent years; taurine can improve body internal specific and non-specific immunity, promotes leukin-1 that lymphocyte produces, and strengthens the activity of neutrophil phagocytosis sterilization; infant immune cell function is played an important role, improves resistance against diseases。
2, blood pressure lowering: taurine plays maintenance electrolyte balance in vivo, can regulate the ratio of potassium and sodium, expels unnecessary sodium ion and the effect keeping blood calcium stable。Clinical observation shows, the hypotensive activity of taurine supplement is not second to depressor。
3, hepatoprotective function of gallbladder promoting: taurine can promote synthesis and the secretion of bile, it is possible to neutralize cytotoxin, wounded hepatocytes has promotion restitution, and can improve liver function, protects liver plasma membrane。Therefore, there is good function of gallbladder promoting, protect the liver and Detoxication。It addition, taurine can also promote that acute hepatitis recovers normal, carbon tetrachloride poisoning is had protective effect, and resists the rising of thus caused serum glutamic pyruvic transminase。
4, blood sugar lowering and prevent and treat complication: research display, taurine has effect of protection insulin cell, can prevent and treat diabetic nephropathy and the hyperglycemia such as diabetic neuropathy and care of patients with diabetic ocular disease other pathological changes caused。
5, prevention and cure of cardiovascular disease: research finds; taurine can suppress platelet aggregation; reduce blood fat; human normal blood pressure can be kept and prevent arteriosclerosis, and the increment of aortal smooth muscle can be suppressed, improving the reconstruct of aorta vessel; myocardial cell also had protective effect; can arrhythmia, the cholesterol level reduced in blood is had special role, and heart failure can be treated。
6, osmotic pressure is regulated: brain or other histiocyte volumes and osmotic pressure are had adjustment effect by taurine。In mammal body, may participate in maintenance cell volume, especially hypernatremia, tax water and occur in uremic situation。Taurine also has important physiological function to maintaining kidney normal function, and has the effect keeping cardiac muscle。
7, resisting fatigue: brain overwork, work and motion and fatigue are had elimination effect by taurine。Research shows, too much free radical can cause nucleic acid main chain and protein cross or polypeptide chain fracture, and biomembrane permeability increases, logistics effusion, cell functional disorders in cell, ATP generates decline, and energy is under-supply and organizes major injury etc., causes that human body ability to work declines and produces fatigue。Taurine has raising body anti-oxidative defense function, and delay fatigue is produced, and improves motor capacity significant。Athlete is after supplementary taurine, and multiple function index all dramatically increases, and test confirms, taurine can improve the content of body LDH vigor and muscle glycogen and hepatic glycogen, reduces Serum lactic acid content, thus body is had antifatigue effect。
(5) Hesperidin (Hesperetin), is present in the fruit of Rutaceae platymiscium Citrus, is a kind of flavone compound, exists at nature in the way of connecting the Hesperidin of a 6-O-.alpha.-L-rhamnosyl-D-glucose.。Hesperidin and Hesperidin are the important effective ingredient of Chinese crude drug Pericarpium Citri Reticulatae, there is physiologically active widely, such as effects such as antioxidation, scavenging free radicals, blood pressure lowering, blood fat reducing, expansion blood vessel, antiplatelet aggregation, atherosclerosis, antiinflammatory, antiallergic, antitumor, preventing and treating cardiovascular system diseases。
Chemical composition: flavone, flavonol, flavanone, procyanidin etc.。
Pharmacological action: 1, blood pressure lowering: research is thought, one of function of human kidney is to secrete " Angiotensin II " making blood pressure increase and " bradykinin " reduced blood pressure to protect the balance of blood pressure。When promoting this two classes material converting Enzyme activity to cross strong, Angiotensin II increases, and blood pressure just rises。Research shows, Hesperidin has the stronger effect suppressing converting Enzyme activity, thereby serves to blood pressure lowering and keeps the effect of blood pressure stabilization。It addition, Hesperidin can also improve the osmotic pressure of blood vessel, it is effectively increased the elasticity of cardiac muscle and blood vessel wall, effectively reduces blood pressure。
2, blood fat reducing: Hesperidin can strengthen Adipocyte Differentiation and conciliate fat effect, reduce plasma cholesterol to assemble, and by suppressing the formation of macrophage to stop atherosclerosis, its effect for reducing fat mechanism be by suppress bile acid repeat absorb, block bile acid at hepato-enteric circulation, thus promoting that internal cholesterol is converted into bile acid in a large number;Its this, the absorption of direct interference metabolism of lipid and cholesterol。It addition, also by the activity suppressing pancreatic lipase, increase triglyceride and discharge from feces, thus the triglyceride levels reduced in blood plasma。Separately having research display, daily intake appropriate Hesperidin patient in one month, internal total cholesterol level reduces 30%, and bad cholesterol reduces 27%, and triglyceride reduces 34%。Therefore, Hesperidin has significant effect for reducing blood fat。
3, myocardial fibrosis is suppressed: myocardial fibrosis is the onset risk that hypertension common complication can dramatically increase myocardial ischemia, left ventricular insufficiency, sudden death, affects cardiac function。Research finds, Hesperidin can suppress the active oxygen that Angiotensin II is induced to produce, and then suppresses fibroblast synthesis, and secretes I, type III collagen protein, strengthens synthesis and the expression of degradation of cell epimatrix;Additionally, Hesperidin suppresses fibroblastic propagation also by the generation of inhibitory activity oxygen。Therefore, result of study shows, Hesperidin can suppress myocardial fibrosis, then improves remodeling ventricle。
4, antithrombotic: have research display, researcher adopts and the feedstuff of thrombosis can be caused to feed rat, and it is found that the Feed Energy that Hesperidin processed makes the prolonged survival period of rat, it was shown that Hesperidin has antithrombotic effect。Additionally, human body platelet experiments show that, a certain amount of Hesperidin can effectively suppress the platelet aggregation that epinephrine is induced, and can stop leukocyte and erythrocytic polymerization。Therefore, there is antithrombotic effect。
5, antiinflammatory: Hesperidin has Citrin sample effect。Results of animal shows, Hesperidin can antagonizing histamine。The mice vascular permeability that LYSOLECITHIN SUNLECITHIN A causes increases。Research shows, Hesperidin can suppress lipopolysaccharide inflammatory model mice carrageenin to cause the release of scorching edemous rat tumor necrosin, and its antiinflammatory action is by itself direct acting result。
6, antioxidation: research display, Hesperidin has good antioxidant activity。Hesperidin can press down the generation of organic free radical and hydroxy radical, it is suppressed that in conjunction with the generation of the active oxygen factor and active oxygen in cell, thus playing antiopxidant effect。
Additionally, Hesperidin also has anti-gastric-ulcer, blood pressure lowering, fat-reducing, antibacterial, uvioresistant, antitumor, the effects such as clinic is additionally operable to treatment hypertension, coronary heart disease, functional dyspepsia。
(6) cocoa polyphenol (CocoaPolyphenls), is the seed (title cacao bean) of Sterculiaceae aiphyllium cocoa tree。Being a kind of plant chemical ingredient extracted from cacao bean, human body, with multiple activity hydroxies, is had many bioactive functions by its chemical constitution。As fat-reducing, blood fat reducing, blood pressure lowering, blood sugar lowering, enhancing immunity, protect the liver, prevention and cure of cardiovascular disease, antioxidation, defying age, the effect such as anticancer。
Chemical composition: cocoa polyphenol contains flavonoid, phenol and phenolic acids, poly-anthocyanidin B1, poly-anthocyanidin B2, poly-anthocyanidin C, alkaloids etc.。
Physiological function: 1, weight-reducing: cocoa polyphenol can promote oxidation and the decomposition of fat, reduce the fat accumulation at abdominal part, the activity of liver fat synzyme can also be suppressed, thus reducing the synthesis of body fat, and Liver fatty deposition, also can stop fat absorption in intestinal simultaneously, promote that fat is discharged from feces。Studies in China confirms, obese rat is had obvious antiobesity action by cocoa polyphenol, and zoopery confirms, the obesity index of rat, fat has obvious reduction, has significant fat-reducing effect。Its mechanism of action is that cocoa polyphenol can promote fat oxidation and metabolism, it is suppressed that the activity of carbohydrase and suppression lipase, promotes that fat is discharged from feces, thus reaching the effect of fat-reducing。
According to external, scientist's research shows, cocoa polyphenol can effectively suppress neutral fat in blood to increase, and stops fat absorption in intestinal, it was demonstrated that cocoa polyphenol has obvious fat-reducing effect。
2, blood pressure lowering, research is thought, one of function of human kidney is secrete " Angiotensin II " that make blood pressure increase and is that blood pressure reduces " bradykinin " to keep the balance of blood pressure。When the enzymatic activity promoting two class material conversions is crossed strong, Angiotensin II increase, blood pressure just rises, and cocoa polyphenol has the stronger effect suppressing converting Enzyme activity, draws and can play reduction and keep the effect of blood pressure stabilization。Separately having been reported that, cocoa polyphenol can improve the permeability of blood vessel, can be effectively increased cardiac muscle and vessel wall elasticity, effectively reduce blood pressure。
3, blood fat reducing suppresses atherosclerosis: Human Lipid Metabolism is had important effect by cocoa polyphenol。Can substantially suppress the rising of cholesterol in blood plasma and liver, there is the effect promoting that lipid excretes from feces, therefore, have and prevent arteriosclerosis。Experiment confirms, cocoa polyphenol can make T-CHOL and triglyceride in serum decline about 19%, can the ratio of high density lipoprotein increasing and low density lipoprotein, LDL, ratio difference 36.1% before and after experiment, the mechanism of its cocoa polyphenol blood fat reducing is the absorption by suppressing the exogenous cholesterol of intestinal, accelerates the metabolism of cholesterol and promotes excretion。The absorption of exogenous triglyceride is reduced by the activity of suppression pancreatic lipase。
4, blood sugar lowering: diabetes are too high by insufficient insulin and blood glucose and the glycolipid fat that causes and protein metabolism disorder。The metabolism obstacles of blood glucose of human body is had adjustment effect by cocoa polyphenol, it is possible to reduce blood sugar level, it is thus possible to effectively prevent and treatment diabetes。According to another relevant report, cocoa polyphenol suppresses the human body absorbability to glucose。The hydrolysis two ways of its mechanism of action absorption and reduction carbohydrate mainly through stoping glucose reduces blood sugar content。The enzymes such as α-amylase can make starch or carbohydrate degradation be monosaccharide and not by intestinal absorption。Therefore, it is suppressed that the activity of this fermentoid can make the generation of monosaccharide decline, thus reducing blood sugar concentration。
5, scavenging free radicals, slow down aging: cocoa polyphenol can effectively remove free radical too much in human body, protect membrane structure, reducing human is old and feeble。Experiments show that the cocoa polyphenol emulative and combined with radical of energy terminates the chain reaction of free radical, thus preventing and alleviating the excessive free radicals damage to human body, reaches to remove the effect of disease and health。Because the structure-rich phenolic hydroxy group of tea multienzyme, phenolic group structure have higher stability, therefore, cocoa polyphenol has obvious scavenging free radicals and delaying senility function。
6, antioxidation: substantial amounts of experiments show that, cocoa polyphenol has effect of very strong antioxidation and physiologically active and scavenging free radicals, and it can stop the reaction of disconnected fat oxidation, scavenging capacity enzyme, reaches antioxidative effect。It is reported, Japanese scholars research is existing, and cocoa polyphenol is a kind of strong antioxidant, and the halmatogenesis of cell is had very strong inhibitory action。
7, immunologic function is strengthened: it is demonstrated experimentally that body's immunity is had multiple effect by cocoa polyphenol。It is mainly manifested in by lowering cellular superoxide compounds content or regulating immunity by removing the excessive free radical generated in immune response pathway;And cocoa polyphenol has the dual function of endogenous antioxidant and exogenous antioxidant concurrently; therefore there is the resultant effect of mutually coordinated effect; the body of immunologic hypofunction is irritated promotion immunity raising effect (as delaying human body thymus fails by it; protection lymphocyte is impaired; promote the activity of thymocytes proliferation; irritate antibody activity change etc.), and normal body's immunity is had certain mediation protective effect, epidemic prevention allergy。Very important effect is had in improving immunologic function。
8, relieving constipation: research proves, intestinal microbial population is selectively acted on by cocoa polyphenol, to harmful bacteria inhibitory action, as suppressed staphylococcus, Bacillus proteus, probiotics being had activation, Lactococcus, lactobacillus and bacillus bifidus etc., thus effectively facilitating health。It addition, cocoa polyphenol can also strengthen intestinal contraction and wriggling function, accelerate gastric emptying, internal harmful substance is excreted in time, reaches the purpose of relieving constipation。The mechanism of cocoa polyphenol relieving constipation mainly can increase contraction and the creeping effect of large intestine。
In sum: this product has the effects such as blood pressure lowering, blood fat reducing, blood sugar lowering, fat-reducing, relieving constipation, preventing and treating cardiovascular and cerebrovascular disease, anti-cancer and cancer-preventing。
Six, processing technology: 1, allotment mixing: all raw materials in formula are mixed by physical characteristic。
2, stirring: the raw material mixed is stirred。
3, test package: the raw material that will stir, checks qualified packaging to become formal product。
Allotment mixing is that by physical characteristic, the raw material in formula is carried out mixed processes。Stirring is the operation stirred by the raw material mixed。Test package is that qualified for the ingredient inspection stirred packaging is become formal product。
Seven, quality standard:
1, physical and chemical index
2, dose: every day 3 times, each 1 bag (30 grams)
3, suitable population: be adapted to each age group blood pressure lowering crowd。
Eight, detailed description of the invention:
Embodiment: take Semen avenae nudae extract 10-100 kilogram, fish protein tripeptides 5-10 kilogram, ubiquinone101-2 kilogram, taurine 3-7 kilogram, Hesperidin 5-8 kilogram, cocoa polyphenol 5-10 kilogram be raw material, through above raw material is mixed, stir, sending into packer becomes pouch by design quantity packaging, and it is qualified to check, and is packaged as finished product。
Claims (1)
1. Semen avenae nudae blood pressure lowering tea (electuary) processing technology, is characterized by: Semen avenae nudae extract 10-100 kilogram, fish protein tripeptides 5-10 kilogram, ubiquinone101-2 kilogram, taurine 3-7 kilogram, Hesperidin 5-8 kilogram, cocoa polyphenol 5-10 kilogram be raw material, through above raw material is mixed, stir, send into packer by not having juice consumption to be packaged as pouch, it is qualified to check, and is packaged as finished product。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610154782.3A CN105685325A (en) | 2016-03-18 | 2016-03-18 | Highland barley blood pressure reducing tea (instant herbal medicine) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610154782.3A CN105685325A (en) | 2016-03-18 | 2016-03-18 | Highland barley blood pressure reducing tea (instant herbal medicine) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105685325A true CN105685325A (en) | 2016-06-22 |
Family
ID=56231219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610154782.3A Pending CN105685325A (en) | 2016-03-18 | 2016-03-18 | Highland barley blood pressure reducing tea (instant herbal medicine) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105685325A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102077934A (en) * | 2010-09-20 | 2011-06-01 | 王强 | Special dietary marine food for patients with high blood pressure |
CN102125127A (en) * | 2011-01-18 | 2011-07-20 | 西藏月王生物技术有限公司 | Functional highland barley red yeast rice tea and preparation method thereof |
CN102422949A (en) * | 2011-11-05 | 2012-04-25 | 西藏正和吉玛科技有限公司 | Hordeum vulgare L.var.nudum hook.f. health preservation tea drink and processing technology thereof |
-
2016
- 2016-03-18 CN CN201610154782.3A patent/CN105685325A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102077934A (en) * | 2010-09-20 | 2011-06-01 | 王强 | Special dietary marine food for patients with high blood pressure |
CN102125127A (en) * | 2011-01-18 | 2011-07-20 | 西藏月王生物技术有限公司 | Functional highland barley red yeast rice tea and preparation method thereof |
CN102422949A (en) * | 2011-11-05 | 2012-04-25 | 西藏正和吉玛科技有限公司 | Hordeum vulgare L.var.nudum hook.f. health preservation tea drink and processing technology thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109452521B (en) | Auxiliary uric acid peptide reducing solid beverage, preparation method and application | |
CN101248900B (en) | Novel solid sport drink medicinal granules | |
CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN101606704B (en) | Dietary fiber food with various functional actions | |
CN105285952A (en) | Meal replacement powder with balanced nutrients and preparation method of meal replacement powder | |
CN106261763A (en) | A kind of grain dietary fiber meal replacement powder and preparation method thereof | |
CN101715913B (en) | Capsule for regulating blood fat and production process thereof | |
CN101507494A (en) | Special diet food for patient with hyperlipidemia and hypertension | |
CN106107463A (en) | Super Quinoa Antifatigue milk tea processing technology | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
CN104855985A (en) | Non-complete-nutrition formula food for high uric acid | |
CN103431377A (en) | Foodstuff capable of reducing blood pressure and preventing complications | |
CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
CN107279978A (en) | A kind of special medicine purposes formula food suitable for tumour patient | |
CN103156108A (en) | Fortified food for preventing and treating diabetes mellitus and hypertension diseases | |
CN105661547A (en) | Probiotics and Bombyx mori compounded diabetic patient nutritional supplement | |
CN111543605A (en) | Comprehensive nutrition powder for people with hypertension, hyperlipidemia and obesity | |
CN110916200A (en) | Uric acid reducing composition and preparation method thereof | |
CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
CN105613882A (en) | Black barley hypoglycemic tea (milky tea) | |
CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
KR20110105627A (en) | Anti-obesity composition containing silkworm hemolymph | |
WO2008140064A1 (en) | Nutrient composition for prevention and amelioration of lifestyle-related disease | |
CN106174286A (en) | Senior gold Chinese-wolfberry nutritive fruit jam | |
JP2004329047A (en) | Dietary supplement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160622 |